We are live on ! Find out more
ProShare Advisors

ProShare Advisors Portfolio holdings

AUM $67.5B
1-Year Est. Return 28.09%
This Fund
S&P 500
This Quarter Est. Return
+8.87%
1 Year Est. Return
+28.09%
3 Year Est. Return
+88.43%
5 Year Est. Return
+118.21%
10 Year Est. Return
+464.8%
AUM
$34.2B
AUM Growth
+$2.41B
Cap. Flow
-$59.6M
Cap. Flow %
-0.17%
Top 10 Hldgs %
26.19%
Holding
2,465
New
206
Increased
1,202
Reduced
956
Closed
98

Top Buys

Rank Stock Value
1
JNJ icon
Johnson & Johnson
JNJ
+$31.6M
2
PETS icon
PetMed Express
PETS
+$29.7M
3
ALB icon
Albemarle
ALB
+$27.7M
4
WMT icon
Walmart Inc
WMT
+$27.2M
5
NEE icon
NextEra Energy
NEE
+$27M

Sector Composition

Rank Sector Weight
1 Technology 25.69%
2 Consumer Discretionary 14.5%
3 Communication Services 10.43%
4 Healthcare 10.27%
5 Financials 9.84%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WSR
2301
DELISTED
Whitestone REIT
WSR
$95K ﹤0.01%
11,478
-350
-3% -$3.15K
TNXP icon
2302
Tonix Pharmaceuticals
TNXP
$157M
0
KLDO
2303
DELISTED
Kaleido Biosciences, Inc. Common Stock
KLDO
$94K ﹤0.01%
+12,665
New +$89.8K
WTTR icon
2304
Select Water Solutions
WTTR
$2.51B
$93K ﹤0.01%
15,323
-424
-3% -$2.45K
UAVS icon
2305
AgEagle Aerial Systems
UAVS
$41.4M
$91K ﹤0.01%
+17
New +$93.2K
LCTX icon
2306
Lineage Cell Therapeutics
LCTX
$257M
$90K ﹤0.01%
+31,459
New +$81.4K
SCOR icon
2307
Comscore
SCOR
$110M
$89K ﹤0.01%
892
+83
+10% +$6.51K
RMO
2308
DELISTED
Romeo Power, Inc.
RMO
$88K ﹤0.01%
+10,847
New +$92.6K
ACTG icon
2309
Acacia Research
ACTG
$450M
$86K ﹤0.01%
12,720
+6
+0% +$36
EZPW icon
2310
Ezcorp Inc
EZPW
$1.82B
$86K ﹤0.01%
14,226
-248
-2% -$1.57K
IBIO icon
2311
iBio
IBIO
$71M
$85K ﹤0.01%
112
-2
-2% -$1.46K
YELL
2312
DELISTED
Yellow Corporation Common Stock
YELL
$85K ﹤0.01%
+13,061
New +$97.2K
NNBR icon
2313
NN Inc
NNBR
$272M
$82K ﹤0.01%
11,089
-115
-1% -$864
AMPE
2314
DELISTED
Ampio Pharmaceuticals Inc.
AMPE
$82K ﹤0.01%
+164
New +$88.1K
CTSO icon
2315
Cytosorbents Corp
CTSO
$22.6M
$81K ﹤0.01%
10,697
-278
-3% -$2.34K
LXRX icon
2316
Lexicon Pharmaceuticals
LXRX
$1.02B
$81K ﹤0.01%
17,612
+4,323
+33% +$20.8K
CSLT
2317
DELISTED
CASTLIGHT HEALTH, INC.
CSLT
$81K ﹤0.01%
+30,983
New +$57.7K
LITS
2318
Lite Strategy Inc
LITS
$33.6M
$80K ﹤0.01%
1,406
-59
-4% -$3.79K
NPKI
2319
NPK International
NPKI
$1.21B
$80K ﹤0.01%
23,147
-845
-4% -$2.87K
BNED icon
2320
Barnes & Noble Education
BNED
$412M
$78K ﹤0.01%
+108
New +$87.1K
NCMI icon
2321
National CineMedia
NCMI
$354M
$77K ﹤0.01%
1,527
-137
-8% -$6.42K
LTRPA
2322
DELISTED
Liberty TripAdvisor Holdings, Inc. Series A
LTRPA
$77K ﹤0.01%
18,902
-522
-3% -$2.53K
NBEV
2323
DELISTED
NewAge, Inc. Common Stock (Delaware)
NBEV
$77K ﹤0.01%
34,543
+9,197
+36% +$21.4K
ATHX
2324
DELISTED
Athersys, Inc. Common Stock
ATHX
$75K ﹤0.01%
2,086
+232
+13% +$9.54K
QTNT
2325
DELISTED
Quotient Limited Ordinary Shares
QTNT
$74K ﹤0.01%
509
+25
+5% +$4K

Similar funds

ProShare Advisors's Q2 2021 Portfolio in Review

As of Q2 2021, ProShare Advisors held 2,465 positions worth $34.2B, up 7.6% from $31.8B the previous quarter. Its ten largest holdings account for 26% of the portfolio.

ProShare Advisors's Q2 2021 filing shows 206 new, 1,202 increased, 956 reduced and 98 closed positions. Its largest new stake was Trinity Industries: 371,743 shares worth $10M. The largest sale was Amazon, an estimated $155M.

By sector, the portfolio is most concentrated in Technology at 26% of assets, up from 26% a quarter earlier, followed by Consumer Discretionary and Communication Services.

  • ProShare Advisors's largest Q2 2021 buy was Trinity Industries: 371,743 shares worth $10M.
  • ProShare Advisors added most to Johnson & Johnson in Q2 2021, an estimated $31.6M increase.
  • ProShare Advisors's biggest Q2 2021 reduction was Amazon, cutting an estimated $155M.
  • ProShare Advisors fully exited Just Eat Takeaway.com N.V. American Depositary Shares in Q2 2021, selling an estimated $60.1M.
  • ProShare Advisors's ten largest holdings make up 26% of its $34.2B portfolio in Q2 2021.
  • ProShare Advisors opened 206 new positions and closed 98 in Q2 2021.
  • ProShare Advisors's portfolio value rose 7.6% quarter-over-quarter to $34.2B.

Based on ProShare Advisors's 13F filing for Q2 2021, filed 13 Aug 2021.